Denali Therapeutics Inc. — Investor Relations & Filings
Filings indexed
748
across all filing types
Latest filing
2026-05-21
Regulatory Filings
Country
US
United States of America
Listing
US
DNLI
Denali Therapeutics Inc. is a biopharmaceutical company dedicated to discovering and developing therapies for neurodegenerative diseases, lysosomal storage disorders, and other serious illnesses. The company's core scientific strategy centers on its proprietary Transport Vehicle™ (TV) platform, which is engineered to transport large therapeutic molecules, such as antibodies and enzymes, across the blood-brain barrier. This technology is designed to overcome a primary obstacle in treating diseases of the central nervous system. Denali's pipeline comprises a portfolio of investigational drug candidates that leverage this platform to target the underlying genetic and biological pathways of complex diseases.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-21 | English | |
| 8-K - Denali Therapeutics Inc. (0001714899) (Filer) | 2026-05-07 | English | |
| ARS - Denali Therapeutics Inc. (0001714899) (Filer) | 2026-04-21 | English | |
| 8-K - Denali Therapeutics Inc. (0001714899) (Filer) | 2026-04-03 | English | |
| 8-K - Denali Therapeutics Inc. (0001714899) (Filer) | 2026-03-31 | English | |
| SCHEDULE 13G/A - Denali Therapeutics Inc. (0001714899) (Subject) | 2026-03-26 | English |
Browse filings by year
10 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46798656 | 8-K | 2026-05-21 | English | ||
| 43481399 | 8-K - Denali Therapeutics Inc. (0001714899) (Filer) | 2026-05-07 | English | ||
| 34922372 | ARS - Denali Therapeutics Inc. (0001714899) (Filer) | 2026-04-21 | English | ||
| 33294542 | 8-K - Denali Therapeutics Inc. (0001714899) (Filer) | 2026-04-03 | English | ||
| 33115075 | 8-K - Denali Therapeutics Inc. (0001714899) (Filer) | 2026-03-31 | English | ||
| 33052821 | SCHEDULE 13G/A - Denali Therapeutics Inc. (0001714899) (Subject) | 2026-03-26 | English | ||
| 33042395 | 8-K - Denali Therapeutics Inc. (0001714899) (Filer) | 2026-03-25 | English | ||
| 32897173 | 10-K - DENALI THERAPEUTICS INC. (0001714899) (Filer) | 2026-02-26 | English | ||
| 32897172 | 8-K - DENALI THERAPEUTICS INC. (0001714899) (Filer) | 2026-02-26 | English | ||
| 13058155 | FORM 4 | 2026-01-08 | English | ||
| 13058157 | FORM 4 | 2026-01-08 | English | ||
| 13058154 | Regulatory Filings 2026 | 2026-01-07 | English | ||
| 13058156 | Regulatory Filings 2026 | 2026-01-07 | English | ||
| 13058158 | Regulatory Filings 2026 | 2026-01-07 | English | ||
| 13058160 | 8-K | 2026-01-06 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AC Immune SA
Biopharmaceutical firm developing precision medicine for ne…
|
ACIU | CH | Manufacturing |
|
Aclaris Therapeutics, Inc.
Clinical-stage biopharmaceutical company developing drugs f…
|
ACRS | US | Manufacturing |
|
Acrivon Therapeutics, Inc.
Clinical-stage biopharma using proteomics to develop precis…
|
ACRV | US | Manufacturing |
|
ACRUX LIMITED
Develops and commercializes topical and transdermal drug de…
|
ACR | AU | Manufacturing |
|
Acticor Biotech
Develops treatments for thrombotic diseases, focusing on ac…
|
ALACT | FR | Manufacturing |
|
Actinium Pharmaceuticals, Inc.
Clinical-stage company developing targeted radiotherapies f…
|
ATNM | US | Manufacturing |
|
ACTUATE THERAPEUTICS, INC.
Clinical-stage biopharma developing therapies for cancers w…
|
ACTU | US | Manufacturing |
|
AcuCort AB
Develops user-friendly drug formulations for severe and acu…
|
ACUC | SE | Manufacturing |
|
Acumen Pharmaceuticals, Inc.
Clinical-stage biopharma developing targeted therapies for …
|
ABOS | US | Manufacturing |
|
Acurx Pharmaceuticals, Inc.
Clinical-stage biopharma developing a new class of antibiot…
|
ACXP | US | Manufacturing |
Denali Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31637/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31637 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31637 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31637 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31637}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Denali Therapeutics Inc. (id: 31637)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.